- Home
- PNTG vs LYEL Comparison
PNTG vs LYEL Comparison
Compare PNTG & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNTG
- LYEL
- Stock Information
- Founded
- PNTG 2019
- LYEL 2018
- Country
- PNTG United States
- LYEL United States
- Employees
- PNTG N/A
- LYEL N/A
- Industry
- PNTG Medical/Nursing Services
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- PNTG Health Care
- LYEL Health Care
- Exchange
- PNTG Nasdaq
- LYEL Nasdaq
- Market Cap
- PNTG 805.7M
- LYEL 207.7M
- IPO Year
- PNTG N/A
- LYEL 2021
- Fundamental
- Price
- PNTG $25.51
- LYEL $9.84
- Analyst Decision
- PNTG Buy
- LYEL Sell
- Analyst Count
- PNTG 6
- LYEL 2
- Target Price
- PNTG $35.17
- LYEL $15.00
- AVG Volume (30 Days)
- PNTG 286.8K
- LYEL 149.3K
- Earning Date
- PNTG 08-05-2025
- LYEL 08-06-2025
- Dividend Yield
- PNTG N/A
- LYEL N/A
- EPS Growth
- PNTG 40.99
- LYEL N/A
- EPS
- PNTG 0.76
- LYEL N/A
- Revenue
- PNTG $748,167,000.00
- LYEL $65,000.00
- Revenue This Year
- PNTG $25.01
- LYEL N/A
- Revenue Next Year
- PNTG $8.19
- LYEL N/A
- P/E Ratio
- PNTG $33.13
- LYEL N/A
- Revenue Growth
- PNTG 30.04
- LYEL N/A
- 52 Week Low
- PNTG $21.18
- LYEL $7.65
- 52 Week High
- PNTG $37.13
- LYEL $38.40
- Technical
- Relative Strength Index (RSI)
- PNTG 35.33
- LYEL 52.64
- Support Level
- PNTG $25.50
- LYEL $9.11
- Resistance Level
- PNTG $26.53
- LYEL $10.41
- Average True Range (ATR)
- PNTG 1.07
- LYEL 0.61
- MACD
- PNTG -0.32
- LYEL 0.04
- Stochastic Oscillator
- PNTG 6.32
- LYEL 70.77
About PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.